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A B S T R A C T
Background: Easy access to eﬀective over-the-counter (OTC) treatments allows self-management of some con-
ditions, however inappropriate or incorrect supply or use of OTC medicines can cause harm. Pharmacy personnel
should support consumers in their health-seeking behaviour by utilising eﬀective communication skills under-
pinned by clinical knowledge.
Objective: To identify interventions targeted towards improving communication between consumers and phar-
macy personnel during OTC consultations in the community pharmacy setting.
Methods: Systematic review and narrative analysis. Databases searched were MEDLINE, EMBASE, Psycinfo,
Cochrane Central Register and Cochrane Database of Systematic Reviews for literature published between 2000
and 30 October 2014, as well as reference lists of included articles. The search was re-run on 18 January 2016
and 25 September 2017 to maximise the currency. Two reviewers independently screened retrieved articles for
inclusion, assessed study quality and extracted data. Full publications of intervention studies were included.
Participants were community pharmacy personnel and/or consumers involved in OTC consultations.
Interventions which aimed to improve communication during OTC consultations in the community pharmacy
setting were included if they involved a direct measurable communication outcome. Studies reporting attitudes
and measures not quantiﬁable were excluded. The protocol was published on Prospero Database of Systematic
Reviews.
Results: Of 4978 records identiﬁed, 11 studies met inclusion criteria. Interventions evaluated were: face-to-face
training sessions (n=10); role-plays (n= 9); a software decision making program (n= 1); and simulated pa-
tient (SP) visits followed by immediate feedback (n= 1). Outcomes were measured using: SP methodology
(n=10) and a survey (n= 1), with most (n=10) reporting a level of improvement in some communication
behaviours.
Conclusion: Empirical evaluation of interventions using active learning techniques such as face-to-face training
with role-play can improve some communication skills. However interventions that are not fully described limit
the ability for replication and/or generalisability. This review identiﬁed interventions targeting pharmacy
personnel. Future interventions to improve communication should consider the consumer's role in OTC con-
sultations.
1. Introduction
Many countries reclassify prescription medicines as over-the-
counter (OTC) medicines to increase public access and reduce national
drug expenditure. OTC medicines have also been reclassiﬁed to reduce
demand on health service providers, including general practice and
emergency departments.1–4 In addition, self-management with OTC
medicines can increase personal empowerment and facilitate access to
eﬀective treatments.2 The inappropriate or incorrect supply or use of
OTC medicines can, however, cause harm.2,5 As such, consumers who
seek access to OTC medicines from community pharmacies should be
supported in their health-seeking behaviour by pharmacy personnel.
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Pharmacy personnel engaging in OTC consultations require clinical
skills underpinned by clinical knowledge. Clinical knowledge forms the
foundation for understanding what information needs to be gathered
from the consumer and how to cognitively process the information to
formulate a course of action that will facilitate an appropriate outcome
for the consumer. For these clinical skills to be eﬀective, pharmacy
personnel must utilise eﬀective communication skills – both verbal and
non-verbal. This may include developing rapport, engaging the con-
sumer, structuring the explanations according to the needs of the con-
sumer and use of open ended questions. Increasing the amount of
quality information exchange during OTC consultations is signiﬁcantly
associated with positive outcomes such as appropriate medicine supply
or referral.6–9 There is substantial evidence, however, that the man-
agement of the diverse range of OTC enquiries encountered in com-
munity pharmacies is sub-optimal and that this is mainly due to in-
adequate information gathering and/or advice or information provision
by pharmacy personnel.6,10–14
This literature review forms part of a larger study which aims to
develop, implement and evaluate an intervention to enhance OTC
consultations between pharmacy personnel and consumers in commu-
nity pharmacies. The review will be used to inform the development of
the intervention.
Objective: To identify interventions targeted towards improving
communication between consumers and pharmacy personnel during
OTC consultations in the community pharmacy setting.
2. Methods
A systematic literature review was performed according to standard
methods. The review protocol was published on PROSPERO.15
2.1. Deﬁnitions
For the purpose of this review, the deﬁnition of a community
pharmacy was a property registered as a pharmacy which was staﬀed
by one or more qualiﬁed pharmacists. Over-the-counter (OTC) medi-
cines were deﬁned as medicines that are supplied without a prescrip-
tion from a community pharmacy. An OTC consultation was deﬁned as
a health request, not associated with a prescription, for the consumer
themselves or on someone else's behalf. This could have been a request
for a speciﬁc product by name or for advice about treatment of a
symptom or condition. A consumer was deﬁned as a person visiting the
community pharmacy for an OTC request.
Study designs were deﬁned as: randomised controlled trial (RCT)
where participants were randomly allocated to an intervention or
control group, controlled trials where a control group was used but
random allocation was not reported, and before-and-after studies where
outcomes were measured pre- and post-intervention.
2.2. Data sources
An information specialist from the University of Aberdeen with
expertise in conducting systematic reviews was consulted in the de-
velopment of the search strategy. Databases searched were MEDLINE,
EMBASE, Psycinfo, Cochrane Central Register and Cochrane Database
of Systematic Reviews for literature published between 2000 and 30
October 2014 using a combination of Medical Subject Heading (MeSH)
terms and text words. The search was re-run on 18 January 2016 and
25 September 2017 to maximise the currency of this review. Authors of
conference abstracts that met the inclusion criteria were contacted to
ascertain if the study had subsequently been published in full.
Supplementary search methods were used, including scanning re-
ference lists of all full-text articles that met the inclusion criteria and a
search for relevant theses using the ProQuest database. In addition, a
request for relevant publications was posted on ResearchGate from 18
December 2014 until 12 May 2015.
Search terms and strategy are listed in Supplementary ﬁle 1.
2.2.1. Inclusion criteria
2.2.1.1. Studies. Full publications of intervention studies. No other
limits regarding study design were applied. No limits were applied
for language and non-English publications were translated.
2.2.1.2. Participants. Participants were community pharmacy
personnel (pharmacist and non-pharmacist) and/or consumers
involved in OTC consultations. No restrictions were imposed on the
age of study participants.
2.2.1.3. Interventions. Interventions which aimed to improve
communication during OTC consultations in the community
pharmacy setting were included.
2.2.1.4. Outcomes. Interventions were included if they involved a
direct measurable communication outcome. Examples of these
measures included: the number of closed and/or open questions
asked by pharmacy personnel; types of questions asked (general or
speciﬁc); information elicited; and, prompted/unprompted consumer
information seeking/provision.
Eligibility was assessed using independent duplicate screening (LS,
KW) with disagreements being resolved by discussion and consensus.
2.2.2. Exclusion criteria
Studies reporting attitudes and measures that were not quantiﬁable
were excluded.
2.2.3. Data extraction
A data extraction tool was developed and underwent duplicate in-
dependent testing (LS, KW) using 3 articles randomly selected from
included articles. Disagreements between the 2 reviewers were dis-
cussed and resolved and the data extraction tool subsequently reﬁned.
Independent duplicate abstraction was undertaken for all included
manuscripts. Disagreement was resolved by consensus and involvement
of a third researcher when required (LH). Information extracted in-
cluded the study design and characteristics of the intervention such as
the mode of delivery, duration, content, theoretical underpinning, set-
ting and follow-up. The communication outcome measures were noted
with how they were measured and if the measurement method had
been validated. The outcome ﬁndings, number of participants, their age
range and if they were pharmacists or pharmacy assistants were re-
corded. Information on sampling and how study conditions were as-
signed was extracted and for RCTs also randomisation and blinding
information.
2.2.4. Risk of bias and quality of reporting
Independent duplicate risk of bias assessment was undertaken using
a checklist developed from the Cochrane Collaboration Risk of Bias
tool16 and the Template for Intervention Description and Replication
(TIDieR)17 for quality of reporting.
2.2.5. Data analysis
Due to the heterogeneity of methods, the results are presented as a
narrative analysis and reported using the format recommended by the
Preferred Reporting Items for Systematic Reviews and Meta-analyses
(PRISMA) statement.18
3. Results
The search strategy identiﬁed 7326 records of which 2348 dupli-
cates were removed resulting in 4978 records (Fig. 1). After excluding
4950 records through the title and abstract screening, 29 full-text ar-
ticles were retrieved for further evaluation. One article identiﬁed in the
supplementary search was found to be an additional report on a study
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already included and was therefore excluded.19 The authors of one
conference abstract provided information regarding the subsequent full
publication which was included in the full text assessment for elig-
ibility. Eleven articles were identiﬁed as meeting the inclusion criteria
(Table 1), comprising RCTs (n= 6),20–25 controlled trial (n= 1)26 and
before-and-after studies (n=4)27−31 from Germany (n=3),23,26,29
Australia (n= 2),22,30,31 Scotland (n=2)20,24 and one each from the
United States of America,27 Switzerland,21 Vietnam28 and Thailand.25
One study26 was published in German and was translated into English
for the review by two Master of Pharmacy students who were studying
in English with German as their ﬁrst language.
All studies incorporated multiple components to the interventions
(Table 1). Interventions evaluated were: face-to-face training sessions
(n=10)21−30; role-plays (n= 9)21,22,24−28,30; a software decision
making program (n=1)29; and simulated patient (SP) visits followed
by immediate feedback (n= 1).20 Outcomes were measured using: SP
methodology (n= 10)20−22,24−30 and a survey (n=1),23 with most
(n=10)21−30 reporting a level of improvement in some communica-
tion behaviours.
3.1. Quality of reporting and risk of bias
Six of the 11 included studies were RCTs.20–25 An additional study26
claiming to be an RCT reported that as “random assignment to groups
was not possible” study conditions were allocated sequentially. There-
fore, for the purposes of this review, this study was categorised as a
controlled trial26 (Table 1). Four studies provided justiﬁcation for the
sample size20,21,24,25 and of these 3 achieved the sample size.20,21,25
Risk of bias was variable with none of the RCTs documenting all the
Cochrane Risk of Bias elements (Table 2).
In the controlled trial,26 participants were sequentially assigned to
the intervention and control groups and were blinded to their alloca-
tion. The method for determining sample size was unclear. Telephone
calls from SPs were used to measure outcomes. During the SP telephone
calls, one researcher was the SP, noting down responses on a checklist.
Another researcher listened in and also recorded the responses thus
increasing the reliability of the data collected. Reasons for non-com-
pletion were clearly documented.
A further 9 studies used SPs to measure outcomes. In one study the
SP interaction was overt and not audio-recorded,29 in 5 studies there
was no audio-recording of SP visits22,25,27,28,30 and in the remaining 3
studies the SP visits were audio recorded,21,24,32 thereby reducing recall
bias.
The quality of reporting of the interventions was variable when
assessed against the TIDieR Checklist17 (Table 3). One study24 reported
10 checklist items, while a second study,20 involving some of the same
authors, reported 9 of the 11 applicable items. Most studies20–22,24,26–29
described the materials used in interventions with about half reporting
who20,24,28–30 delivered the intervention and where20,24,26,29,30 it was
delivered. A single study24 reported if modiﬁcations to the intervention
were made during the study. Six studies20–22,24,28,29 described the plans
for determining the ﬁdelity of the intervention, with none reporting if
the plans were followed through.
3.1.1. Intervention characteristics
The UK Medical Research Council recommends using theory to
systematically develop complex interventions and to fully describe the
intervention for implementation and replication.33 Five20–22,24,27 of the
11 interventions were underpinned by one or more theories and in-
cluded Self Eﬃcacy Theory,27 Stages of Change,21 Health Beliefs
Model,21 the Social Cognitive Theory,22 Agenda-Led Outcome Based
Analysis (ALBOA) model of feedback,20 Theory of Planned Behaviour24
Fig. 1. PRISMA ﬂow-chart of study selection
process.
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and Cognitive Behavioural Therapy technique.24 Three studies21,22,24
reported the rationale for the selected theory and how it was used in the
development of the intervention.
Face-to-face training events which incorporated a knowledge com-
ponent and a role-play component were used in 821–28 of the 11 studies.
Typically, these consisted of a workshop which incorporated a knowl-
edge section followed by role-play (Table 1). The knowledge compo-
nent was either clinically-oriented or focussed on behaviour and com-
munication skills. Speciﬁc clinical areas included topics such as
smoking cessation,27 emergency contraception,25 dyspepsia,23 and
childhood diarrhoea.28 Other workshops addressed more general skills
development. These included developing an understanding of beha-
viour models,21,22,24 the use of interview frameworks22,26,27 and com-
munication techniques designed to be ﬂexible,21,24 helping pharmacy
personnel to use open-ended questions to assess consumers' respon-
siveness as well as to guide them through questioning.
One before-and-after study30 reported the use of a training event but
the content of this was determined at each intervention site and was
therefore variable and not described. Another before-and-after study29
utilised one-to-one training on the use of a software program to assist
decision making for allergic rhino-conjunctivitis OTC enquiries by
working through an algorithm. This was immediately followed by overt
SP role-play assessment.
In one RCT20 a diﬀerent approach was undertaken whereby the
intervention included provision of feedback immediately following a SP
visit. Three SP visits were conducted: one baseline and 2 follow-up
visits, with immediate feedback provided after visits one and two. Be-
haviour change was measured by comparing visit one (before any
feedback) with visit three (after 2 sessions of feedback).
Duplicate coding of the behaviour change techniques34,35 utilised in
the interventions was performed and identiﬁed to be: demonstration of
the behaviour; instruction on how to perform the behaviour; feedback
on behaviour; behavioural practise/rehearsal; social support; and
prompts/cues (Table 1). Between 2 and 5 behaviour change techniques
were reported per intervention.
3.1.2. Outcomes
Outcomes were assessed primarily with the use of SP visits to
pharmacies where participants worked.20–22,24,25,27,28,30 SP visits in-
volved an enquiry which aﬀorded the pharmacist or pharmacy assistant
an opportunity to display communication skills relevant to the study
aim. After the interaction the SP recorded what had occurred on a
standardised form. For example, in a before and after study27 phar-
macists were trained to enhance smoking cessation interactions using
the 5As technique: Ask; Assess; Advise; Assist; Arrange. The commu-
nication outcome measure was the SP record of the pharmacist's use of
the 5As technique in the interaction. Changes in the scores before and
after the training were analysed for signiﬁcance (Table 1).
SP visits were used to measure changes in communication beha-
viour in 621,22,24,25,27,28 of the 8 studies involving a face-to-face training
session with role-play. There was improvement with some commu-
nication outcome measures in these 6 studies with statistically sig-
niﬁcant improvements reported in 5 studies21,22,25,27,28 (Table 1). A
further study involving a workshop with role-play, measured commu-
nication after the intervention using SP telephone consultations. Sig-
niﬁcant improvements in some consultation elements were shown in
the intervention group compared with the control group.26 The inter-
vention in the ﬁnal RCT study involved face-to-face training with role-
play and did not involve SPs.23 Consumers visiting a pharmacy for help
with dyspepsia or a speciﬁc medicine for dyspepsia were asked to
complete a survey about the interaction immediately following the
encounter with the pharmacist. A signiﬁcant increase in the number of
questions and advice-giving was shown in the intervention group
compared with the control group.
One before-and-after study explored the eﬀect of training on the use
of Pharmacist Decision Support System software and assessed the eﬀectTa
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using the number of mandatory questions asked (according to the
Federal Union of German Associations of Pharmacists) such as who the
patient is, what they symptoms are, and how often they occur.29 The
trainer also acted as an SP and role-played a scenario immediately
before and after the training. Signiﬁcant increases were reported in the
number of mandatory questions asked post-training.
A larger before-and-after study30 involved a variable and un-
speciﬁed education intervention and health promotion activity con-
cerning salbutamol inhaler requests with the eﬀects being measured by
SP visits. Results (Table 1) showed that the number of visits in which
salbutamol was supplied without any patient assessment was sig-
niﬁcantly lower in the intervention group, as was the number of visits
without counselling. The mean number of assessment questions asked
and counselling points provided per pharmacy visit were also sig-
niﬁcantly greater in the intervention group.
A pilot RCT20 investigated the eﬀectiveness of covert SP visits
combined with immediate individualised feedback, delivered by either
SPs or pharmacy educators. The Mann–Whitney test revealed no dif-
ference in total WWHAM36 (Who is it for, What are the symptoms, How
long have the symptoms been present, Any medication tried already,
other Medication taken) score between the study groups at any time.
The eﬀectiveness of the interventions in the 11 studies was eval-
uated at diﬀerent time-points following the interventions (Table 1).
Some were evaluated immediately after the intervention,27,29,32 with
many having successive SP visits over a period of months21,22,24–28,30,32
(although the timeframe was often poorly reported). Only one study28
conducted SP visits over an extended (4 year) period.
4. Discussion
This systematic review identiﬁed 11 interventions that were con-
ducted with the aim of improving communication between pharmacy
personnel and consumers during OTC consultations in the community
pharmacy setting. The methods and quality varied and there was no
consistent deﬁnition for good communication or consultation skills
provided. All but one study23 assessed changes in communication skills
using SP methodology, which has been shown to be a valid method of
measuring practice interactions between pharmacy personnel and
consumers.37,38 The other method used to assess communication skills
was a survey of consumers.23
The researchers reported that the use of active learning through
training using role-play, feedback and reﬂection was important for
development of and improvement in communication skills. Active
learning “involves students in doing things and thinking about the
things they are doing”.39 It gained momentum as a method for en-
hancing learning in the 1990's39–41 with recent research in pharmacy
teaching and learning still ﬁnding the method eﬀective in learning
communication skills.42,43 Studies identiﬁed in the review which used
workshops to improve knowledge in a speciﬁc clinical area and also
incorporated an active role-play component resulted in improved
communication between pharmacy personnel and consumers. Sig-
niﬁcant improvements in communication were reported in 421,22,26,27
of the 5 studies where the focus of the workshop was not clinical
knowledge, but rather communication skills and an understanding of
models of health behaviour. Two of these studies did not present sample
size calculations22,26 and one used a purposive sample27 making the
Table 2
Risk of bias of RCT (n= 6) and controlled trial studies (n= 1).
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impact of these results diﬃcult to determine. Only one study did not
show signiﬁcant improvements in communication, however this was a
pilot study.24 Role-play, feedback and reﬂection were also used with
positive results in the intervention that used SPs to visit pharmacies
covertly, then provide feedback to the staﬀ member immediately
afterwards.20 These ﬁndings are consistent with literature reporting on
the eﬀectiveness of active learning techniques to enhance and maintain
existing as well as develop new skills.44,45
Consultation skills have been taught to health professionals using a
number of methods including the use of structured interview frame-
works such as WHAMM (Who is the patient and what are the symp-
toms? How long have symptoms been present? Action taken.
Medication being taken.),36 the Calgary Cambridge Guide46 and moti-
vational interviewing techniques. These methods have been shown to
be more eﬀective when used with active learning techniques.44
The search for interventions to improve communication between
pharmacy personnel and consumers during OTC consultations in the
community pharmacy setting identiﬁed interventions in which the
target participants were pharmacy personnel. However, the role of the
consumer in the two way consultation process should also be con-
sidered. Consultations that involve a speciﬁc product request have been
shown to involve less information exchange than consultations where
consumers ask about management of a symptom.47,48 While this may
indicate a failure of pharmacy personnel asking questions with speciﬁc
product requests, it might also indicate that consumers see these to be
transactional interactions rather than consultations. Engaging the con-
sumer in the consultation process, particularly when they request a
speciﬁc product, may improve consultation outcomes.
In the UK's guidance for developing and evaluating complex inter-
ventions it is recommended that interventions are developed using the
best available evidence and a sound theoretical basis.33 Having a
thorough theoretical understanding is essential for determining how the
intervention causes change and resources have been developed to assist
researchers to evaluate behaviour change.34,49 The guidance also em-
phasises the importance of fully describing the intervention to facilitate
evaluation and replication by others.17 As the information from this
review is to be used to inform the development of an intervention the
quality of the reporting was of particular interest. Only 3 of the studies
that were underpinned with theory provided details of how this was
achieved.21,22,24 Two of these attributed improved communication
skills to the interventions delivered however details regarding compo-
nents which were considered eﬀective were not provided.21,22 Fully
describing these components to enable an understanding of the active
constituents of the intervention and replication is essential but was not
evidenced in these studies. Detailed information would also beneﬁt
future researchers by enabling them to identify previously tested in-
tervention components that were eﬀective to use as a basis for sub-
sequent research. Equally, when ineﬀective intervention components
are fully reported they can be avoided in future research, or in-
vestigated to determine why they were not eﬀective. An analysis to
determine the behaviour change techniques used in the included stu-
dies was performed. The interventions conducted were to educate (in-
crease knowledge or understanding) and/or train (impart skills) phar-
macy personnel.34,35
Table 3
The TIDieR checklist for included studies (n= 11).
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4.1. Strengths and limitations
This review was conducted using a systematic approach complying
with the PRISMA statement.18 The search strategy was comprehensive
and used multiple supplementary search methods. Eligibility criteria
were limited to studies that involved an intervention with a direct
communication measure involving OTC enquiries in the community
pharmacy setting.
Studies were not excluded based on risk of bias, quality, sample size
or power and therefore the evidence presented here should be inter-
preted with caution.
5. Conclusion
There has been some empirical evaluation of interventions to en-
hance communication during OTC consultations. The use of face-to-face
training with role-play has been shown to improve some communica-
tion skills however the active components of these interventions have
not been fully described. Future research should endeavour to identify
behaviour change techniques appropriate for interventions and provide
a detailed account of the intervention to enable replication and/or
generalisability.
All studies targeted pharmacy personnel with none targeting con-
sumers. Future interventions to improve communication should con-
sider all participants in OTC consultations.
Conﬂicts of interest
Authors (M C Watson and R M Cliﬀord) of this review article had
authored papers that met the inclusion criteria for the review, however
were not involved in the screening, data abstraction or appraisal pro-
cesses.
Funding
This research did not receive any speciﬁc grant from funding
agencies in the public, commercial, or not-for-proﬁt sectors.
Acknowledgement
We would like to thank Cynthia Fraser, Information Specialist at the
Health Services Research Unit at the University of Aberdeen for her
contribution to this review by assisting with the development of the
search strategy.
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://dx.
doi.org/10.1016/j.sapharm.2017.12.001.
References
1. Therapeutic Goods Administration. Reasons for Scheduling Delegate's Final Decisions.
June 2017; June 2017https://www.tga.gov.au/scheduling-decision-ﬁnal/
scheduling-delegates-ﬁnal-decisions-june-2017, Accessed date: 29 August 2017.
2. Hughes CM, McElnay JC, Fleming GF. Beneﬁts and risks of self medication. Drug Saf.
2001;24:1027–1037.
3. Pharmacy Guild of Australia. The Roadmap: The Strategic Direction for Community
Pharmacy. 2010; 2010www.guild.org.au/docs/default-source/public-documents/
tab–-the-guild/Strategic-Direction/here-.pdf?sfvrsn=02010, Accessed date: 29
August 2017.
4. Cohen JP, Paquette C, Cairns CP. Switching prescription drugs to over the counter. Br
Med J. 2005;330:39–41.
5. Blenkinsopp A, Bradley C. Patients, society, and the increase in self medication. Br
Med J. 1996;312:629–632.
6. Watson MC, Hart J, Johnston M, Bond CM. Exploring the supply of non-prescription
medicines from community pharmacies in Scotland. Pharm World Sci.
2008;30:526–535.
7. Dwamena F, Holmes-Rovner M, Gaulden CM, et al. Interventions for providers to
promote a patient-centred approach in clinical consultations. Cochrane Database Syst
Rev. 2012;12:CD003267.
8. Watson MC, Ferguson J, Barton GR, et al. A cohort study of inﬂuences, health out-
comes and costs of patients' health-seeking behaviour for minor ailments from pri-
mary and emergency care settings. Br Med J. 2015;5:e006261.
9. Berger K, Eickhoﬀ C, Schulz M. Counselling quality in community pharmacies: im-
plementation of the pseudo customer methodology in Germany. J Clin Pharm Ther.
2005;30:45–57.
10. Watson M, Bond C, Grimshaw J, Johnston M. Factors predicting the guideline
compliant supply (or non-supply) of non-prescription medicines in the community
pharmacy setting. Qual Saf Health Care. 2006;15:53–57.
11. Watson MC, Bond CM, Johnston M, Mearns K. Using human error theory to explore
the supply of nonprescription medicines from community pharmacies. Qual Saf
Health Care. 2006;15:244–250.
12. Schneider CR, Everett AW, Geelhoed E, Kendall PA, Cliﬀord RM. Measuring the as-
sessment and counselling provided with the supply of non-prescription asthma re-
liever medication: a simulated patient study. Ann Pharmacother. 2009;43:1512–1518.
13. Schneider CR, Emery L, Brostek R, Cliﬀord RM. Evaluation of the supply of antifungal
medication for the treatment of vaginal thrush in the community pharmacy setting: a
randomized controlled trial. Pharm Pract (Granada). 2013;11:132–137.
14. Benrimoj SI, Werner JB, Raﬀaele C, Roberts AS, Costa FA. Monitoring quality stan-
dards in the provision of non-prescription medicines from Australian Community
Pharmacies: results of a national programme. Qual Saf Health Care.
2007;16:354–358.
15. Seubert L, Whitelaw K. Enhancing communication between consumers and com-
munity pharmacy staﬀ for over the counter requests: a systematic review of inter-
vention studies: PROSPERO; 2014.
16. Higgins JPT, Green S. Cochrane handbook for Systematic Reviews of Interventions
Version 5.1.0. vol. 5. 2011; 2011 The Cochrane Collaboration.
17. Hoﬀmann TC, Glasziou PP, Boutron I, et al. Better reporting of interventions: tem-
plate for intervention description and replication (TIDieR) checklist and guide. Br
Med J. 2014;348:g1687.
18. Moher D, Liberati A, Tetzlaﬀ J, Altman DG. Preferred reporting items for systematic
reviews and meta-analyses: the PRISMA statement. Br Med J. 2009;339:332–336.
19. Minh PD, Huong DT, Byrkit R, Murray M. Strengthening pharmacy practice in
vietnam: ﬁndings of a training intervention study. Trop Med Int Health.
2013;18:426–434.
20. Watson MC, Cleland JA, Bond CM. Simulated patient visits with immediate feedback
to improve the supply of over-the-counter medicines: a feasibility study. Fam Pract.
2009;26:532–542.
21. Sigrist T, Benrimoj SI, Hersberger K, Langford J. Changing pharmacists' and phar-
macist assistants' practice in dealing with direct requests for non-prescription an-
algesics. Int J Pharm Pract. 2002;10:23–29.
22. de Almeida Neto AC, Benrimoj SI, Kavanagh DJ, Boakes RA. A pharmacy based
protocol and training program for non-prescription analgesics. Res Soc Adm Pharm.
2000;17:183–192.
23. Krishnan HS, Schaefer M. Evaluation of the impact of pharmacist's advice giving on
the outcomes of self-medication in patients suﬀering from dyspepsia. Pharm World
Sci. 2000;22:102–108.
24. Watson MC, Cleland J, Inch J, Bond CM, Francis J. Theory-based communication
skills training for medicine counter assistants to improve consultations for non-pre-
scription medicines. Med Educ. 2007;41:450–459.
25. Ratanajamit C, Chongsuvivatwong V, Geater AF. A randomized controlled educa-
tional intervention on emergency contraception among drugstore personnel in
southern Thailand. J Am Med Womens Assoc (1972). 2002;57:196–199 207.
26. Laven A, Schafer J, Laer S. PHARMAGRIPS: structured pharmaceutical counseling in
the self-medication of the common cold. A randomised controlled study (RCT).
Medizinische Monatsschrift Fur Pharmazeuten. 2014;37:209–220.
27. Martin BA, Chewning BA. Evaluating pharmacists' ability to counsel on tobacco
cessation using two standardized patient scenarios. Patient Educ Couns.
2011;83:319–324.
28. Pham DM, Byrkit M, Pham HV, Pham T, Nguyen CT. Improving pharmacy staﬀ
knowledge and practice on childhood diarrhea management in Vietnam: are edu-
cational interventions eﬀective? PLos One. 2013;8:e74882.
29. Bertsche T, Nachbar M, Fiederling J, et al. Assessment of a computerised decision
support system for allergic rhino-conjunctivitis counselling in German pharmacy. Int
J Clin Pharm. 2012;34:17–22.
30. Schneider CR, Everett AW, Geelhoed E, et al. Intern pharmacists as change agents to
improve the practice of nonprescription medication supply: provision of salbutamol
to patients with asthma. Ann Pharmacother. 2010;44:1319–1326.
31. Collins JC, Schneider CR, Faraj R, Wilson F, de Almeida Neto AC, Moles RJ.
Management of common ailments requiring referral in the pharmacy: a mystery
shopping intervention study. Int J Clin Pharm. 2017;39:697–703.
32. Watson MC, Cleland JA, Bond CM. Simulated patient visits with immediate feedback
to improve the supply of over-the-counter medicines: a feasibility study. Fam Pract.
2009;26:532–542.
33. Medical Research Council. Developing and Evaluating Complex Interventions: New
Guidance. UK. 2008; 2008https://www.mrc.ac.uk/documents/pdf/complex-
interventions-guidance, Accessed date: 29 August 2017.
34. Michie S, Richardson M, Johnston M, et al. The behavior change technique taxonomy
(v1) of 93 hierarchically clustered techniques: building an international consensus
for the reporting of behavior change interventions. Ann Behav Med. 2013;46:81–95.
35. Michie S, Atkins L, West R. The Behaviour Change Wheel. A Guide to Designing
Interventions. 1st Great Britain: Silverback Publishing; 2014.
36. Blenkinsopp A, Paxton P, Blenkinsopp J. Symptoms in the Pharmacy: A Guide to the
Management of Common Illness. Oxford: Blackwell Publishing Ltd; 2009.
37. Watson MC, Skelton JR, Bond CM, et al. Simulated patients in the community
L.J. Seubert et al. Research in Social and Administrative Pharmacy 14 (2018) 979–988
987
pharmacy setting. Using simulated patients to measure practice in the community
pharmacy setting. Pharm World Sci. 2004;26:32–37.
38. Watson MC, Norris P, Granas AG. A systematic review of the use of simulated pa-
tients and pharmacy practice research. Int J Pharm Pract. 2006;13:83–93.
39. Bonwell CC, Eison JA. Active Learning: Creating Excitement in the Classroom. 1991
ASHE-ERIC Higher Education Reports. ERIC; 1991.
40. Grabinger RS, Dunlap JC. Rich environments for active learning: a deﬁnition. ALT-J.
1995;3:5–34.
41. Prince M. Does active learning Work? A review of the research. J Eng Educ.
2004;93:223–231.
42. Collier IA, Baker DM. Creation of an active learning healthcare communications
course using simulations relevant to pharmacy practice. Curr Pharm Teach Learn.
2017;9:626–632.
43. Mesquita AR, Souza WM, Boaventura TC, et al. The eﬀect of active learning meth-
odologies on the teaching of pharmaceutical care in a Brazilian pharmacy faculty.
PLos One. 2015;10:e0123141.
44. Lane C, Rollnick S. The use of simulated patients and role-play in communication
skills training: a review of the literature to August 2005. Patient Educ Couns.
2007;67:13–20.
45. Heaven C, Clegg J, Maguire P. Transfer of communication skills training from
workshop to workplace: the impact of clinical supervision. Patient Educ Couns.
2006;60:313–325.
46. Greenhill N, Anderson C, Avery A, Pilnick A. Analysis of pharmacist-patient com-
munication using the Calgary-Cambridge guide. Patient Educ Couns.
2011;83:423–431.
47. Puumalainen II, Peura SH, Kansanaho HM, Benrimoj CSI, Airaksinen MSA. Progress
in patient counselling practices in Finnish community pharmacies. Int J Pharm Pract.
2005;13:149–156.
48. John DN, Krska J, Hansford D. Are customers requesting medicines by name less
likely to be advised or referred? Provision of over-the-counter H2-receptor antago-
nists and alginate products from pharmacies. Int J Pharm Pract. 2003;11:33–39.
49. Michie S, West R, Campbell R, Brown J, Gainforth H. ABC of Behaviour Change
Theories. Great Britain: Silverback Publishing; 2014.
L.J. Seubert et al. Research in Social and Administrative Pharmacy 14 (2018) 979–988
988
